The potential benefit of stem cell therapy after stroke: an update | Zendy

Soma Banerjee | Zendy; Chataway | Zendy; Deborah A. Williamson | Zendy; Nagy Habib | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The potential benefit of stem cell therapy after stroke: an update

Author(s) -

Soma Banerjee,

Chataway,

Deborah A. Williamson,

Nagy Habib

Publication year - 2012

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s25745

Subject(s) - medicine , stroke (engine) , clinical trial , intensive care medicine , stem cell therapy , stem cell , stroke recovery , medline , physical therapy , rehabilitation , pathology , surgery , transplantation , mechanical engineering , engineering , biology , political science , law , genetics

Stroke is a leading cause of death and disability worldwide. Stem cell therapy is an emerging therapeutic modality with evidence of significant benefits in preclinical stroke models. A number of phase I and II clinical trials have now been completed, with several more currently under way. Translation to the bedside, however, remains a long way off, and there are many questions that remain unanswered. This review will summarize the current evidence and ongoing clinical trials worldwide, and explore the challenges to making this a realistic treatment option for the future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research